Literature DB >> 12539744

High prevalence of viable Toxoplasma gondii infection in market weight pigs from a farm in Massachusetts.

J P Dubey1, H R Gamble, D Hill, C Sreekumar, S Romand, P Thuilliez.   

Abstract

The ingestion of uncooked infected meat is considered important in the epidemiology of Toxoplasma gondii infection in humans and little is known of the prevalence of viable T. gondii in meat used for human consumption in the United States. In the present study, viable T. gondii was isolated from 51 out of 55 pigs destined for human consumption. Hearts and tongues (500 g) from fifty-five 6-mo-old pigs from a farm in Massachusetts were bioassayed for T. gondii by feeding them to T. gondii-free cats. Feces of these cats were examined for shedding of T. gondii oocysts. Fifty-one of 55 cats fed pig tissues each shed 25-810 million T. gondii oocysts in their feces. Two of these cats consumed tissues of pigs that were shown to be seronegative with the Sabin-Feldman dye test, the modified agglutination test, and the Western blot. Results indicate that until examination of meat for T. gondii infection is implemented in slaughterhouses, all meat should be cooked according to industry guidelines before human consumption.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12539744     DOI: 10.1645/0022-3395(2002)088[1234:HPOVTG]2.0.CO;2

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  15 in total

Review 1.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  cDNA microarray analysis of host-pathogen interactions in a porcine in vitro model for Toxoplasma gondii infection.

Authors:  Margaret Okomo-Adhiambo; Craig Beattie; Anette Rink
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Detection of Toxoplasma gondii in naturally infected domestic pigs in Northern Serbia.

Authors:  Ljiljana Kuruca; Ivana Klun; Aleksandra Uzelac; Aleksandra Nikolić; Branko Bobić; Stanislav Simin; Vesna Lalošević; Dušan Lalošević; Olgica Djurković-Djaković
Journal:  Parasitol Res       Date:  2017-09-27       Impact factor: 2.289

4.  Seroprevalence of Toxoplasma gondii in Iberian pig sows.

Authors:  Alba Pablos-Tanarro; Luis Miguel Ortega-Mora; Antonio Palomo; Francisco Casasola; Ignacio Ferre
Journal:  Parasitol Res       Date:  2018-03-13       Impact factor: 2.289

5.  Seroprevalence of anti-Toxoplasma gondii antibodies in cattle and pigs in Ibadan, Nigeria.

Authors:  ThankGod Emmanuel Onyiche; Isaiah Oluwafemi Ademola
Journal:  J Parasit Dis       Date:  2013-09-03

Review 6.  Epidemiology of and diagnostic strategies for toxoplasmosis.

Authors:  Florence Robert-Gangneux; Marie-Laure Dardé
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

Review 7.  Genetic diversity of Toxoplasma gondii in animals and humans.

Authors:  L David Sibley; Asis Khan; James W Ajioka; Benjamin M Rosenthal
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-09-27       Impact factor: 6.237

8.  Toxoplasma gondii infection in slaughter pigs in Serbia: seroprevalence and demonstration of parasites in blood.

Authors:  Ivana Klun; Marija Vujanić; Hélène Yera; Aleksandra Nikolić; Vladimir Ivović; Branko Bobić; Siniša Bradonjić; Jean Dupouy-Camet; Olgica Djurković-Djaković
Journal:  Vet Res       Date:  2011-02-01       Impact factor: 3.683

9.  Neospora caninum and/or Toxoplasma gondii Seroprevalence: Vaccination against PCV2 and Muscle Enzyme Activity in Seropositive and Seronegative Pigs.

Authors:  Labrini V Athanasiou; Vasileios G Papatsiros; Victoria M Spanou; Eleni G Katsogiannou; Anna Dedousi
Journal:  Microorganisms       Date:  2021-05-20

10.  Prevalence and risk factors of Toxoplasma gondii in fattening pigs farm from Yucatan, Mexico.

Authors:  A Ortega-Pacheco; K Y Acosta Viana; E Guzmán-Marín; J C Segura-Correa; M Alvarez-Fleites; M Jiménez-Coello
Journal:  Biomed Res Int       Date:  2013-06-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.